Gonadotropin releasing hormone and transforming growth factor β activate mitogen-activated protein kinase/extracellularly regulated kinase and differentially regulate fibronectin, type I collagen, and plasminogen activator inhibitor-1 expression in leiomyoma and myometrial smooth muscle cells

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 11, 2004, Pages 5549-5557

  Ding, Li ^a   Xu, Jingxia ^a   Luo, Xiaoping ^a   Chegini, Nasser ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; COLLAGEN TYPE 1; FIBRONECTIN; GONADORELIN DERIVATIVE; LEUPRORELIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN C FOS; PROTEIN C JUN; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL SPECIFICITY; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LEIOMYOMA; MYOMETRIUM; ONCOGENE C FOS; ONCOGENE C JUN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; TRANSCRIPTION INITIATION; TUMOR GROWTH; TUMOR REGRESSION;

COLLAGEN TYPE I; ENZYME ACTIVATION; FEMALE; FIBRONECTINS; GENE EXPRESSION REGULATION; GENES, FOS; GENES, JUN; GONADOTROPIN-RELEASING HORMONE; HUMANS; LEIOMYOMA; MITOGEN-ACTIVATED PROTEIN KINASES; MYOCYTES, SMOOTH MUSCLE; MYOMETRIUM; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRANSFORMING GROWTH FACTOR BETA; UTERINE NEOPLASMS;

EID: 8744246378     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-0161     Document Type: Article

References (51)

1. Chegini N 2000 Implication of growth factor and cytokine networks in leiomyomas. In: Hill J, ed. Cytokines in human reproduction. New York: Wiley & Sons; 133-162
2. Takeuchi H, Kobori H, Kikuchi I, Sato Y, Mitsuhashi N 2000 A prospective randomized study comparing endocrinological and clinical effects of two types of GnRH agonists in cases of uterine leiomyomas or endometriosis. J Obstet Gynaecol Res 26:325-331
3. Kettel LM, Murphy AA, Morales AJ, Rivier J, Vale W, Yen SS 1993 Rapid regression of uterine leiomyomas in response to daily administration of gonadotropin-releasing hormone antagonist. Fertil Steril 60:642-646
4. Chegini N, Rong H, Dou Q, Kipersztok S, Williams RS 1996 Gonadotropin releasing hormone (GnRH) and GnRH receptor gene expression in human myometrial and leiomyomata and the direct action of GnRH analogs on myometrial smooth muscle cells interaction with ovarian steroids in vitro. J Clin Endocrinol Metab 81:3215-3221
5. Raga F, Casan EM, Kruessel JS, Wen Y, Huang HY, Nezhat C, Polan ML 1998 Quantitative gonadotropin-releasing hormone gene expression and immunohistochemical localization in human endometrium throughout the menstrual cycle. Biol Reprod 59:661-669
6. Grundker C, Gunthert AR, Millar RP, Emons G 2002 Expression of gonadotropin-releasing hormone II (GnRH-II) receptor in human endometrial and ovarian cancer cells and effects of GnRH-II on tumor cell proliferation. J Clin Endocrinol Metab 87:1427-1430
7. Cheon KW, Lee HS, Parhar IS, Rang IS 2001 Expression of the second isoform of gonadotrophin-releasing hormone (GnRH-II) in human endometrium throughout the menstrual cycle. Mol Hum Reprod 7:447-452
8. Straub B, Muller M, Krause H, Schrader M, Miller K 2003 Real-time quantitative reverse transcriptase-polymerase chain reaction for luteinizing hormone-releasing hormone receptor gene mRNA expression in human prostate cancer. Urology 62:172-176
9. van Biljon W, Wykes S, Scherer S, Krawetz SA, Hapgood J 2002 Type II gonadotropin-releasing hormone receptor transcripts in human sperm. Biol Reprod 67:1741-1749
10. Raga F, Casan EM, Wen Y, Huang HY, Bonilla-Musoles F, Polan ML 1999 Independent regulation of matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 (TIMP-1), and TIMP-3 in human endometrial stromal cells by gonadotropin-releasing hormone: implications in early human implantation. J Clin Endocrinol Metab 84:636-642
11. Chegini N, Tang XM, Ma C, Williams RS 2002 Effects of GnRH analogues, 'add-back' steroid therapy, antiestrogen and antiprogestins on leiomyoma and myometrial smooth muscle cell growth and transforming growth factor-β expression. Mol Hum Reprod 8:1071-1078
12. Xu J, Luo X, Chegini N 2003 Differential expression, regulation, and induction of Smads, transforming growth factor-β signal transduction pathway in leiomyoma, and myometrial smooth muscle cells and alteration by gonadotropin-releasing hormone analog. J Clin Endocrinol Metab 88:1350-1361
13. Emons G, Grundker C, Grunthert AR, Westphalen S, Kavanagh J, Verschraegen C 2003 GnRH antagonists in the treatment of gynecological and breast cancers. Endocr Relat Cancer 10:291-299
14. Chou CS, Zhu H, MacCalman CD, Leung PC 2003 Regulatory effects of gonadotropin-releasing hormone (GnRH) I and GnRH II on the levels of matrix metalloproteinase (MMP)-2, MMP-9, and tissue inhibitor of metalloproteinases-1 in primary cultures of human extravillous cytotrophoblasts. J Clin Endocrinol Metab 88:4781-4790
15. Chou CS, MacCalman CD, Leung PC 2003 Differential effects of gonadotropin-releasing hormone I and II on the urokinase-type plasminogen activator/plasminogen activator inhibitor system in human decidual stromal cells in vitro. J Clin Endocrinol Metab 88:3806-3815
16. Meresman GF, Bilotas MA, Lombardi E, Tesone M, Sueldo C, Baranao RI 2003 Effect of GnRH analogues on apoptosis and release of interleukin-1β and vascular endothelial growth factor in endometrial cell cultures from patients with endometriosis. Hum Reprod 18:1767-1771
17. Dou Q, Zhao Y, Tarnuzzer RW, Rong H, Williams RS, Schultz GS, Chegini N 1996 Suppression of transforming growth factor-β (TGF β) and TGF β receptor messenger ribonucleic acid and protein expression in leiomyomata in women receiving gonadotropin-releasing hormone agonist therapy. J Clin Endocrinol Metab 81:3222-3230
18. Chegini N, Luo X, Ding L, Ripley D 2003 The expression of Smads and transforming growth factor β receptors in leiomyoma and myomerrium and the effect of gonadotropin releasing hormone analogue therapy. Mol Cell Endocrinol 209:9-16
19. Massague J, Wotton D 2000 Transcriptional control by the TGF-β/Smad signaling system. EMBO J 19:1745-1754
20. Shi Y, Massague J 2003 Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 113:685-700
21. Blobe GC, Schiemann WP, Lodish HF 2000 Role of transforming growth factor β in human disease. N Engl J Med 342:1350-1358
22. Ripley D, Tang XM, Ma C, Chegini N 2001 The expression and action of granulocyte macrophage-colony stimulating factor and its interaction with TGF-β in endometrial carcinoma. Gynecol Oncol 81:301-309
23. Seli E, Arici A 2003 Endometriosis: interaction of immune and endocrine systems. Semin Reprod Med 21:135-144
24. Dou Q, Tarnuzzer RW, Williams RS, Schultz GS, Chegini N 1997 Differential expression of matrix metalloproteinases and their tissue inhibitors in leiomyomata: a mechanism for gonadotrophin releasing hormone agonist-induced tumour regression. Mol Hum Reprod 3:1005-1014
25. Cheng KW, Leung PC 2000 The expression, regulation and signal transduction pathways of the mammalian gonadotropin-releasing hormone receptor. Can J Physiol Pharmacol 78:1029-1052
26. Klausen C, Chang JP, Habibi HR 2002 Multiplicity of gonadotropin- releasing hormone signaling: a comparative perspective. Prog Brain Res 141:111-128
27. Shah BH, Soh JW, Catt KJ 2003 Dependence of gonadotropin-releasing hormone-induced neuronal MAPK signaling on epidermal growth factor receptor transactivation. J Biol Chem 278:2866-2875
28. Zhang T, Mulvaney JM, Roberson MS 2001 Activation of mitogen-activated protein kinase phosphatase 2 by gonadotropin-releasing hormone. Mol Cell Endocrinol 172:79-89
29. Kraus S, Benard O, Naor Z, Seger R 2003 c-Src is activated by EGF-receptor in a pathway that mediates JNK and ERK activation by gonadotropin-releasing hormone in COS7 cells. J Biol Chem 278:32618-32630
30. Grundker C, Schlotawa L, Viereck V, Emons G 2001 Protein kinase C-independent stimulation of activator protein-1 and c-Jun N-terminal kinase activity in human endometrial cancer cells by the LHRH agonist triptorelin. Eur J Endocrinol 145:651-658
31. Yue J, Mulder KM 2000 Requirement of Ras/MAPK pathway activation by transforming growth factor β for transforming growth factor β1 production in a Smad-dependent pathway. J Biol Chem 275:30765-30773
32. Yakymovych I, Ten Dijke P, Heldin CH, Souchelnytskyi S 2001 Regulation of Smad signaling by protein kinase C. FASEB J 15:553-555
33. Norwitz ER, Xu S, Xu J, Spiryda LB, Park JS, Jeong KH, McGee EA, Kaiser UB 2002 Direct binding of AP-1 (Fos/Jun) proteins to a Smad binding element facilitates both gonadotropin-releasing hormone (GnRH)- and activin-mediated transcriptional activation of the mouse GnRH receptor gene. J Biol Chem 277:37469-37478
34. Norwitz ER, Xu S, Jeong KH, Bedecarrats GY, Winebrenner LD, Chin WW, Kaiser UB 2002 Activin A augments GnRH-mediated transcriptional activation of the mouse GnRH receptor gene. Endocrinology 143:985-997
35. Yamada Y, Yamamoto H, Yonehara T, Kanasaki H, Nakanishi H, Miyamoto E, Miyazaki K 2004 Differential activation of the luteinizing hormone β-subunit promoter by activin and gonadotropin-releasing hormone: a role for the mitogen-activated protein kinase signaling pathway in LβT2 gonadotrophs. Biol Reprod 70:236-243
36. Chegini N, Kornberg L 2003 Gonadotropin releasing hormone analogue therapy alters signal transduction pathways involving mitogen-activated protein and focal adhesion kinases in leiomyoma. J Soc Gynecol Invest 10:21-26
37. Luo X, Xu J, Chegini N 2003 The expression of Smads in human endometrium and regulation and induction in endometrial epithelial and stromal cells by TGF-β. J Clin Endocrinol Metab 88:4967-4976
38. Siler-Khodr TM, Grayson M, Eddy CA 2003 Action of gonadotropin-releasing hormone II on the baboon ovary. Biol Reprod 68:1150-1156
39. Chegini N, Verala J, Luo X, Xu J, Williams RS 2003 Gene expression profile of leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy. J Soc Gynecol Invest 10:61-71
40. Liu F, Austin DA, Mellon PL, Olefsky JM, Webster NJ 2002 GnRH activates ERK1/2 leading to the induction of c-fos and LHβ protein expression in LβT2 cells. Mol Endocrinol 16:419-434
41. Oldenhof AD, Shynlova OP, Liu M, Langille BL, Lye SJ 2002 Mitogen-activated protein kinases mediate stretch-induced c-fos mRNA expression in myometrial smooth muscle cells. Am J Physiol Cell Physiol 283:C1530-C1539
42. Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS, Van Dyk DE, Pitts WJ, Earl RA, Hobbs F, Copeland RA, Magolda RL, Scherle PA, Trzaskos JM 1998 Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 273:18623-18632
43. Vindevoghel L, Lechleider RJ, Kon A, de Caestecker MP, Uitto J, Roberts AB, Mauviel A 1998 SMAD3/4-dependent transcriptional activation of the human type VII collagen gene (COL7A1) promoter by transforming growth factor β. Proc Natl Acad Sci USA 95:14769-14774
44. Mauviel A, Chung KY, Agarwal A, Tamai K, Uitto J 1996 Cell-specific induction of distinct oncogenes of the Jun family is responsible for differential regulation of collagenase gene expression by transforming growth factor-β in fibroblasts and keratinocytes. J Biol Chem 271:10917-10923
45. Gustavsson I, Englund K, Faxen M, Sjoblom P, Lindblom B, Blanck A 2000 Tissue differences but limited sex steroid responsiveness of c-fos and c-jun in human fibroids and myometrium. Mol Hum Reprod 6:55-59
46. Lessl M, Klotzbuecher M, Schoen S, Reles A, Stockemann K, Fuhrmann U 1997 Comparative messenger ribonucleic acid analysis of immediate early genes and sex steroid receptors in human leiomyoma and healthy myometrium. J Clin Endocrinol Metab 82:2596-2600
47. Schnaper HW, Hayashida T, Hubchak SC, Poncelet AC 2003 TGF-β signal transduction and mesangial cell fibrogenesis. Am J Physiol Renal Physiol 284:F243-F252
48. Czuwara-Ladykowska J, Sementchenko VI, Watson DK, Trojanowska M 2002 Ets1 is an effector of the transforming growth factor β (TGF-β) signaling pathway and an antagonist of the profibrotic effects of TGF-β. J Biol Chem 277:20399-20408
49. Reunanen N, Foschi M, Han J, Kahari VM 2000 Activation of extracellular signal-regulated kinase 1/2 inhibits type I collagen expression by human skin fibroblasts. J Biol Chem 275:34634-34639
50. Dhandapani KM, Hadman M, De Sevilla L, Wade MF, Mahesh VB, Brann DW 2003 Astrocyte protection of neurons: role of transforming growth factor-β signaling via a c-Jun-AP-1 protective pathway. J Biol Chem 278:43329-43339
51. Stewart EA, Rhoades AR, Nowak RA 1998 Leuprolide acetate-treated leiomyomas retain their relative overexpression of collagen type I and collagen type III messenger ribonucleic acid. J Soc Gynecol Invest 5:44-47